Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Lacombe

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Seminars in Oncology|February 7, 2004
The European Organisation for Research and Treatment of Cancer strategy for new drug development in brain tumorsDenis Lacombe, Alba A Brandes, Martin van den Bent
Cancer|January 19, 2010
Treatment of small-cell lung cancer in elderly patientsAthanasios G Pallis, Frances A Shepherd, Denis Lacombe, et al.
European Journal of Cancer (Oxford, England : 1990)|April 12, 2026
Empowering the next generation of clinical cancer researchers: Structure, activities, and vision of the European Organisation for Research and Treatment of Cancer (EORTC) Young and Early Career Investigator (Y-ECI) networkIoannis Zerdes, Jens Lehmann, Christine Olungu, et al.
Frontiers in Pharmacology|September 12, 2022
How do cancer clinicians perceive real-world data and the evidence derived therefrom? Findings from an international survey of the European Organisation for Research and Treatment of CancerRobbe Saesen, Georgios Kantidakis, Ann Marinus, et al.
European Journal of Cancer (Oxford, England : 1990)|April 19, 2019
Establishing treatment optimisation as part of personalised medicine developmentDenis Lacombe, Gianluca Quaglio, Stéphane Lejeune, et al.
Frontiers in Medicine|March 3, 2020
Sharing of Clinical Trial Data and Samples: The Cancer Patient PerspectiveStefanie Broes, Ciska Verbaanderd, Minne Casteels, et al.
Frontiers in Pharmacology|March 3, 2020
Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-MakingRobbe Saesen, Stéphane Lejeune, Gianluca Quaglio, et al.
Molecular Oncology|October 29, 2014
The dream and reality of histology agnostic cancer clinical trialsDenis Lacombe, Susen Burock, Jan Bogaerts, et al.
Ecancermedicalscience|May 30, 2013
International clinical trials setting for rare cancers: organisational and regulatory constraints-the EORTC perspectiveEmad Shash, Anastassia Negrouk, Sandrine Marreaud, et al.
European Journal of Cancer (Oxford, England : 1990)|June 3, 2006
Using the continual reassessment method: lessons learned from an EORTC phase I dose finding studyXavier Paoletti, Benoît Baron, Patrick Schöffski, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Seminars in Oncology|February 7, 2004
The European Organisation for Research and Treatment of Cancer strategy for new drug development in brain tumorsDenis Lacombe, Alba A Brandes, Martin van den Bent
Cancer|January 19, 2010
Treatment of small-cell lung cancer in elderly patientsAthanasios G Pallis, Frances A Shepherd, Denis Lacombe, et al.
European Journal of Cancer (Oxford, England : 1990)|April 12, 2026
Empowering the next generation of clinical cancer researchers: Structure, activities, and vision of the European Organisation for Research and Treatment of Cancer (EORTC) Young and Early Career Investigator (Y-ECI) networkIoannis Zerdes, Jens Lehmann, Christine Olungu, et al.
Frontiers in Pharmacology|September 12, 2022
How do cancer clinicians perceive real-world data and the evidence derived therefrom? Findings from an international survey of the European Organisation for Research and Treatment of CancerRobbe Saesen, Georgios Kantidakis, Ann Marinus, et al.
European Journal of Cancer (Oxford, England : 1990)|April 19, 2019
Establishing treatment optimisation as part of personalised medicine developmentDenis Lacombe, Gianluca Quaglio, Stéphane Lejeune, et al.
Frontiers in Medicine|March 3, 2020
Sharing of Clinical Trial Data and Samples: The Cancer Patient PerspectiveStefanie Broes, Ciska Verbaanderd, Minne Casteels, et al.
Frontiers in Pharmacology|March 3, 2020
Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-MakingRobbe Saesen, Stéphane Lejeune, Gianluca Quaglio, et al.
Molecular Oncology|October 29, 2014
The dream and reality of histology agnostic cancer clinical trialsDenis Lacombe, Susen Burock, Jan Bogaerts, et al.
Ecancermedicalscience|May 30, 2013
International clinical trials setting for rare cancers: organisational and regulatory constraints-the EORTC perspectiveEmad Shash, Anastassia Negrouk, Sandrine Marreaud, et al.
European Journal of Cancer (Oxford, England : 1990)|June 3, 2006
Using the continual reassessment method: lessons learned from an EORTC phase I dose finding studyXavier Paoletti, Benoît Baron, Patrick Schöffski, et al.
Pageof 12